Medicine
Vigabatrin 500 mg tablet
Vigabatrin 500 mg tablet is a generic prescription medicine for oral use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F). See USP Controlled Room Temperature.
Key facts
- Active ingredient (INN)
- Vigabatrin
- Brand
- Sold under the generic name
- Strength
- 500 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1 bottle and 5 more
- Manufacturers
- Zydus LifesciencesIndiaAurobindo PharmaIndiaDr. Reddy's LaboratoriesIndiaActavis PharmaCarnegie PharmaceuticalsEdenbridge PharmaceuticalsHikma Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F). See USP Controlled Room Temperature.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N03AG04 Vigabatrin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 6 February 2019
- Identifiers
- RxCUI 199521DailyMed set ID 0afdc84c-f8ec-330a-31c9-fac4ed256931, 5ed8d293-b7d8-4c66-9c31-8075e6f99092, e9c99000-fc0c-4083-b620-ba9ac821f8ac +5NDC 43598-651, 0054-0652, 70771-1654 +5Application ANDA211539, ANDA213104, ANDA215707 +4
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated in 1 bottle | 70710-1287-1 | Zydus LifesciencesIndia | 20 January 2022 |
| 100 tablet, film coated in 1 bottle | 70771-1654-1 | Zydus LifesciencesIndia | 20 January 2022 |
| 1 bottle in 1 carton / 100 tablet in 1 bottle | 59651-367-01 | Aurobindo PharmaIndia | 10 May 2022 |
| 100 tablet, film coated in 1 bottle | 43598-651-01 | Dr. Reddy's LaboratoriesIndia | 1 February 2021 |
| 100 tablet, film coated in 1 bottle | 0591-3851-01 | Actavis Pharma | 6 February 2019 |
| 1 bottle in 1 carton / 100 tablet, film coated in 1 bottle | 80005-167-11 | Carnegie Pharmaceuticals | 18 February 2026 |
| 100 tablet in 1 bottle | 42799-950-01 | Edenbridge Pharmaceuticals | 29 June 2022 |
| 100 tablet in 1 bottle | 0054-0652-25 | Hikma Pharmaceuticals | 9 September 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Vigabatrin 500 mg tablet.
Other strengths and forms of Vigabatrin
Clinical summary
Vigabatrin is an anti-epileptic agent indicated for the treatment of refractory Complex Partial Seizures as adjunctive therapy in patients 2 years of age and older who have responded inadequately to several alternative treatments, among other approved uses. MedsAcross supplies Vigabatrin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about VigabatrinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- SABRIL prescribing information (Lundbeck Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Kigabeq: European public assessment report (EPAR) · European Medicines Agency
Need Vigabatrin 500 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.